表紙
市場調查報告書

癌症基因治療的全球市場 (各類型·各產品·各最終用途):市場規模,產業分析,今後展望·成長可能性,市場佔有率,未來預測 (2019年∼2025年)

Cancer Gene Therapy Market Size By Type By Product, By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025

出版商 Global Market Insights Inc. 商品編碼 920791
出版日期 內容資訊 英文 95 Pages
商品交期: 2-3個工作天內
價格
癌症基因治療的全球市場 (各類型·各產品·各最終用途):市場規模,產業分析,今後展望·成長可能性,市場佔有率,未來預測 (2019年∼2025年) Cancer Gene Therapy Market Size By Type By Product, By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025
出版日期: 2019年10月30日內容資訊: 英文 95 Pages
簡介

全球癌症基因治療的市場規模預測在2025年之前將超越25億美元。全球癌症患病率的上升也對癌症基因治療市場的增長率產生了積極影響。就類型來看,體內部門預計將以22%的速度增長。就各國來看,預計中國市場將以超過26%的複合年增長率增長。

本報告提供全球癌症基因治療的市場相關分析,提供產業的基本結構和技術·法規環境,主要的推動及阻礙市場要素,各類型·各產品·各最終用途·各地區的市場趨勢預測 (過去5年·今後7年份),主要企業的簡介·業績·策略等調查。

第1章 分析方法

第2章 摘要整理

第3章 癌症基因治療產業的考察

  • 產業區分
  • 產業形勢 (2014∼2018年)
  • 對產業的影響要素
    • 成長促進因素
    • 產業的陷阱與課題
  • 成長可能性分析
    • 各類型
    • 各產品
    • 各最終用途
  • 開發平台分析
  • 法規環境
  • 基因治療相關的資本交易
  • 波特的五力分析
  • 競爭環境 (2018年)
    • 策略儀表板
  • PESTEL分析

第4章 癌症基因治療的市場:各類型

  • 各市場區隔的主要趨勢
  • Ex-vivo (生物外)
  • In-vivo (生物內)
    • 市場規模:各地區 (以金額為準,2014∼2025年)

第5章 癌症基因治療的市場:各產品

  • 各市場區隔的主要趨勢
  • 病毒載體
    • 腺病毒
    • 慢病毒
    • 反轉錄病毒
    • 腺結合病毒
    • 單純皰疹病毒
    • 牛痘病毒
    • 其他
  • 非病毒載體
  • 其他

第6章 癌症基因治療的市場:各最終用途

  • 各市場區隔的主要趨勢
  • 生物醫藥品企業
  • 研究機關
  • 其他

第7章 癌症基因治療的市場:各地區

  • 各地區的主要趨勢
  • 北美
    • 市場規模:各國 (以金額為準,2014∼2025年)
    • 市場規模:各類型 (以金額為準,2014∼2025年)
    • 市場規模:各產品 (以金額為準,2014∼2025年)
    • 市場規模:各最終用途 (以金額為準,2014∼2025年)
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 中國
    • 日本

第8章 企業簡介

  • Sirion Biotech
  • Vigene Biosciences
  • Bluebird bio
  • Ziopharm
  • Cellectis
  • Cobra
  • Finvector
  • Uniqure
  • Sarepta Therapeutics
  • Caribou
目錄
Product Code: 763

Title:
Cancer Gene Therapy Market Size By Type (Ex-vivo, In-vivo) By Product (Viral Vectors {Adenoviruses, Lentiviruses, Retrovirus, Adeno Associated Virus, Herpes Simplex Virus, Vaccinia Virus}, Non-viral Vectors), By End-use (Biopharma Companies, Research Institutes), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, China, Japan), Application Potential, Competitive Market Share & Forecast, 2019 - 2025 .

Cancer Gene Therapy Market size is expected to exceed USD 2.5 billion by 2025. Rising cancer prevalence across the globe will positively impact the cancer gene therapy market growth.

Some major findings of the cancer gene therapy market report include:

  • Increasing mortality rates due to cancer has created a huge demand for cancer gene therapies
  • Technological advancements in the biotechnology sectors has led to developments in the cancer gene therapy that are being now preferred by healthcare professionals
  • Regulations for cancer gene therapy are quite structured and stringent in developed economies such as the U.S. and Germany while the regulatory scenario is still ambiguous in emerging economies
  • Cancer gene therapy industry is still in developing phase and yet to witness numerous growth opportunities in the coming years

Some of the major industry players include: Sirion Biotech, Vigene Biosciences, bluebird bio, Ziopharm, Cellectis, Cobra, Finvector, Uniqure, Sarepta Therapeutics, Caribou among others. These industry players adopt several strategic initiatives to maintain their market position.

Technological advancements in the biotechnology sector have led to developments and innovations in cancer gene therapy. Recently developed cancer therapies have been incorporated with genetically modified genes that blocks the growth of tumor. Moreover, efficient PCR technology and isothermal amplification technologies have been introduced that transformed the way of detecting mutations in the genes. Moreover, introduction of CRISPR gene editing tools have modified the process of developing gene therapy. Hence, advancements in technology has ensured availability of advanced cancer gene therapy that will boost the industry growth. However, high cost of cancer gene therapy may impede its demand, thereby restraining the industry growth to certain extent.

Type segment of cancer gene therapy market includes ex-vivo and in-vivo. In-vivo segment is projected to experience around 22% growth throughout the analysis timeframe owing to various advantages associated with it. In-vivo gene therapy involves direct delivery of therapeutic gene into the target cell and has shown effective results in treatment of cancer. The viral vectors that are delivered utilizing in-vivo gene therapy help in inhibiting the activity of tumor inducing genes and has also shown positive results during clinical trials. Aforementioned factors will elevate the segmental growth.

Products of cancer gene therapy include viral vectors and non-viral vectors. Viral vectors segment was valued over USD 310 million in 2018. Viral vectors are highly preferred during gene transfer process as they have showcased high transfection efficiency. Viral vectors possess safety profile as compared to other vectors. Moreover, viral vectors expresses the desired antigen in accurate conformation enhancing the immune system.

End-users of cancer gene therapy are biopharmaceutical companies, research institutes and others. Biopharmaceutical companies segment accounted for around 48% revenue share in 2018 and is expected to experience exceptional growth in the forthcoming years. Companies such as Novartis and Roche are developing cancer gene therapies that have high adoption of viral as well as non-viral vectors, thereby proving beneficial for the segmental growth. These companies also conduct clinical trials that raises the demand for vectors, hence fostering the segmental growth.

China cancer gene therapy market will experience over 26% CAGR throughout the forecast years. Significant country growth can be attributed to the rising awareness regarding the availability of advanced therapies for treating cancer. Furthermore, increasing government initiatives and funds motivate the researchers and scientists for carrying out extensive research activities associated with cancer gene therapy that will positively influence the country growth. Above mentioned factors coupled with increasing prevalence of cancer will further stimulate the industry growth.

Cancer gene therapy industry is dominated by few major players. Cancer gene therapy industry is still in the developing phase, therefore, players involved in thie market focus on integrating advanced technology to promote developments in the therapies. The players also implement certain strategic initiatives such as merger, acquisitions and product launches for acquiring competitive advantage. For instance, in 2013, Celgene and bluebird bio collaborated to introduce innovations in gene therapies. Such collaborations will provide both the companies to gain competitive advantage over others.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definitions
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Cancer gene therapy industry 360 degree synopsis, 2014 - 2025
    • 2.1.1. Business trends
    • 2.1.2. Type trends
    • 2.1.3. Product trends
    • 2.1.4. End-use trends
    • 2.1.5. Regional trends

Chapter 3. Cancer Gene Therapy Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2014 - 2018 (USD Million)
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Increasing prevalence of cancer across the globe
      • 3.3.1.2. Technological advancements in cancer gene therapy in developed regions
      • 3.3.1.3. Rising awareness regarding availability of cancer gene therapy in developing and underdeveloped countries
      • 3.3.1.4. Increasing geriatric population in Europe
    • 3.3.2. Industry pitfalls & challenges
      • 3.3.2.1. High cost of cancer gene therapy
  • 3.4. Growth potential analysis
    • 3.4.1. By type
    • 3.4.2. By product
    • 3.4.3. By end-use
  • 3.5. Pipeline analysis
  • 3.6. Regulatory landscape
  • 3.7. Commercial deals in gene therapy
  • 3.8. Porter's analysis
  • 3.9. Competitive landscape, 2018
    • 3.9.1. Strategy dashboard
  • 3.10. PESTEL analysis

Chapter 4. Cancer Gene Therapy Market, By Type

  • 4.1. Key segment trends
  • 4.2. Ex-vivo
    • 4.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 4.3. In-vivo
    • 4.3.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 5. Cancer Gene Therapy Market, By Product

  • 5.1. Key segment trends
  • 5.2. Viral vectors
    • 5.2.1. Market size, by region, 2014 - 2025 (USD Million)
    • 5.2.2. Adenoviruses
      • 5.2.2.1. Market size, by region, 2014 - 2025 (USD Million)
    • 5.2.3. Lentiviruses
      • 5.2.3.1. Market size, by region, 2014 - 2025 (USD Million)
    • 5.2.4. Retrovirus
      • 5.2.4.1. Market size, by region, 2014 - 2025 (USD Million)
    • 5.2.5. Adeno associated virus
      • 5.2.5.1. Market size, by region, 2014 - 2025 (USD Million)
    • 5.2.6. Herpes simplex virus
      • 5.2.6.1. Market size, by region, 2014 - 2025 (USD Million)
    • 5.2.7. Vaccinia virus
      • 5.2.7.1. Market size, by region, 2014 - 2025 (USD Million)
    • 5.2.8. Others
      • 5.2.8.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.3. Non-viral vectors
    • 5.3.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.4. Others
    • 5.4.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 6. Cancer Gene Therapy Market, By End-use

  • 6.1. Key segment trends
  • 6.2. Biopharma companies
    • 6.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 6.3. Research institutes
    • 6.3.1. Market size, by region, 2014 - 2025 (USD Million)
  • 6.4. Others
    • 6.4.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 7. Cancer Gene Therapy Market, By Region

  • 7.1. Key regional trends
  • 7.2. North America
    • 7.2.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.2.2. Market size, by type, 2014 - 2025 (USD Million)
    • 7.2.3. Market size, by product, 2014 - 2025 (USD Million)
    • 7.2.4. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.2.5. U.S.
      • 7.2.5.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.2.5.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.2.5.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.2.6. Canada
      • 7.2.6.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.2.6.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.2.6.3. Market size, by end-use, 2014 - 2025 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.3.2. Market size, by type, 2014 - 2025 (USD Million)
    • 7.3.3. Market size, by product, 2014 - 2025 (USD Million)
    • 7.3.4. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.3.5. Germany
      • 7.3.5.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.3.5.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.5.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.3.6. UK
      • 7.3.6.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.3.6.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.6.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.3.7. France
      • 7.3.7.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.3.7.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.7.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.3.8. Italy
      • 7.3.8.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.3.8.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.8.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.3.9. Spain
      • 7.3.9.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.3.9.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.9.3. Market size, by end-use, 2014 - 2025 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.4.2. Market size, by type, 2014 - 2025 (USD Million)
    • 7.4.3. Market size, by product, 2014 - 2025 (USD Million)
    • 7.4.4. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.4.5. China
      • 7.4.5.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.4.5.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.4.5.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.4.6. Japan
      • 7.4.6.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.4.6.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.4.6.3. Market size, by end-use, 2014 - 2025 (USD Million)

Chapter 8. Company Profiles

  • 8.1. Sirion Biotech
    • 8.1.1. Business overview
    • 8.1.2. Financial data
    • 8.1.3. Product landscape
    • 8.1.4. Strategic outlook
    • 8.1.5. SWOT analysis
  • 8.2. Vigene Biosciences
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. Bluebird bio
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. Ziopharm
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. Cellectis
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. Cobra
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. Finvector
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. Uniqure
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. Sarepta Therapeutics
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. Caribou
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis

Data Tables

  • TABLE 1. Cancer gene therapy industry 360 degree synopsis, 2014 - 2025
  • TABLE 2. Cancer gene therapy market, 2014 - 2018 (USD Million)
  • TABLE 3. Cancer gene therapy market, 2019 - 2025 (USD Million)
  • TABLE 4. Cancer gene therapy market, by type, 2014 - 2018 (USD Million)
  • TABLE 5. Cancer gene therapy market, by type, 2019 - 2025 (USD Million)
  • TABLE 6. Cancer gene therapy market, by product, 2014 - 2018 (USD Million)
  • TABLE 7. Cancer gene therapy market, by product, 2019 - 2025 (USD Million)
  • TABLE 8. Cancer gene therapy market, by end-use, 2014 - 2018 (USD Million)
  • TABLE 9. Cancer gene therapy market, by end-use, 2019 - 2025 (USD Million)
  • TABLE 10. Cancer gene therapy market, by region, 2014 - 2018 (USD Million)
  • TABLE 11. Cancer gene therapy market, by region, 2019 - 2025 (USD Million)
  • TABLE 12. Industry impact forces
  • TABLE 13. In-vivo market size, by region, 2014 - 2018 (USD Million)
  • TABLE 14. In-vivo market size, by region, 2019 - 2025 (USD Million)
  • TABLE 15. Ex-vivo market size, by region, 2014 - 2018 (USD Million)
  • TABLE 16. Ex-vivo market size, by region, 2019 - 2025 (USD Million)
  • TABLE 17. Viral market size, by region, 2014 - 2018 (USD Million)
  • TABLE 18. Viral market size, by region, 2019 - 2025 (USD Million)
  • TABLE 19. Adenoviruses market size, by region, 2014 - 2018 (USD Million)
  • TABLE 20. Adenoviruses market size, by region, 2019 - 2025 (USD Million)
  • TABLE 21. Lentiviruses market size, by region, 2014 - 2018 (USD Million)
  • TABLE 22. Lentiviruses market size, by region, 2019 - 2025 (USD Million)
  • TABLE 23. Retrovirus market size, by region, 2014 - 2018 (USD Million)
  • TABLE 24. Retrovirus devices market size, by region, 2019 - 2025 (USD Million)
  • TABLE 25. Adeno Associated Virus market size, by region, 2014 - 2018 (USD Million)
  • TABLE 26. Adeno Associated Virus market size, by region, 2019 - 2025 (USD Million)
  • TABLE 27. Herpes Simplex Virus market size, by region, 2014 - 2018 (USD Million)
  • TABLE 28. Herpes Simplex Virus market size, by region, 2019 - 2025 (USD Million)
  • TABLE 29. Vaccinia Virus market size, by region, 2014 - 2018 (USD Million)
  • TABLE 30. Vaccinia Virus devices market size, by region, 2019 - 2025 (USD Million)
  • TABLE 31. Others market size, by region, 2014 - 2018 (USD Million)
  • TABLE 32. Others market size, by region, 2019 - 2025 (USD Million)
  • TABLE 33. Non-viral vectors market size, by region, 2014 - 2018 (USD Million)
  • TABLE 34. Non-viral vectors market size, by region, 2019 - 2025 (USD Million)
  • TABLE 35. Others market size, by region, 2014 - 2018 (USD Million)
  • TABLE 36. Others market size, by region, 2019 - 2025 (USD Million)
  • TABLE 37. Biopharmaceutical companies market size, by region, 2014 - 2018 (USD Million)
  • TABLE 38. Biopharmaceutical companies market size, by region, 2019 - 2025 (USD Million)
  • TABLE 39. Research institutes market size, by region, 2014 - 2018 (USD Million)
  • TABLE 40. Research institutes market size, by region, 2019 - 2025 (USD Million)
  • TABLE 41. Others market size, by region, 2014 - 2018 (USD Million)
  • TABLE 42. Others market size, by region, 2019 - 2025 (USD Million)
  • TABLE 43. North America cancer gene therapy market size, by country, 2014 - 2025 (USD Million)
  • TABLE 44. North America cancer gene therapy market size, by country, 2019 - 2025 (USD Million)
  • TABLE 45. North America cancer gene therapy market size, by type, 2014 - 2018 (USD Million)
  • TABLE 46. North America cancer gene therapy market size, by type, 2019 - 2025 (USD Million)
  • TABLE 47. North America cancer gene therapy market size, by product, 2014 - 2018 (USD Million)
  • TABLE 48. North America cancer gene therapy market size, by product, 2019 - 2025 (USD Million)
  • TABLE 49. North America cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 50. North America cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 51. U.S. cancer gene therapy market size, by type, 2014 - 2018 (USD Million)
  • TABLE 52. U.S. cancer gene therapy market size, by type, 2019 - 2025 (USD Million)
  • TABLE 53. U.S. cancer gene therapy market size, by product, 2014 - 2018 (USD Million)
  • TABLE 54. U.S. cancer gene therapy market size, by product, 2019 - 2025 (USD Million)
  • TABLE 55. U.S. cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 56. U.S. cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 57. Canada cancer gene therapy market size, by type, 2014 - 2018 (USD Million)
  • TABLE 58. Canada cancer gene therapy market size, by type, 2019 - 2025 (USD Million)
  • TABLE 59. Canada cancer gene therapy market size, by product, 2014 - 2018 (USD Million)
  • TABLE 60. Canada cancer gene therapy market size, by product, 2019 - 2025 (USD Million)
  • TABLE 61. Canada cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 62. Canada cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 63. Europe cancer gene therapy market size, by country, 2014 - 2025 (USD Million)
  • TABLE 64. Europe cancer gene therapy market size, by country, 2019 - 2025 (USD Million)
  • TABLE 65. Europe cancer gene therapy market size, by type, 2014 - 2018 (USD Million)
  • TABLE 66. Europe cancer gene therapy market size, by type, 2019 - 2025 (USD Million)
  • TABLE 67. Europe cancer gene therapy market size, by product, 2014 - 2018 (USD Million)
  • TABLE 68. Europe cancer gene therapy market size, by product, 2019 - 2025 (USD Million)
  • TABLE 69. Europe cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 70. Europe cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 71. Germany cancer gene therapy market size, by type, 2014 - 2018 (USD Million)
  • TABLE 72. Germany cancer gene therapy market size, by type, 2019 - 2025 (USD Million)
  • TABLE 73. Germany cancer gene therapy market size, by product, 2014 - 2018 (USD Million)
  • TABLE 74. Germany cancer gene therapy market size, by product, 2019 - 2025 (USD Million)
  • TABLE 75. Germany cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 76. Germany cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 77. UK cancer gene therapy market size, by type, 2014 - 2018 (USD Million)
  • TABLE 78. UK cancer gene therapy market size, by type, 2019 - 2025 (USD Million)
  • TABLE 79. UK cancer gene therapy market size, by product, 2014 - 2018 (USD Million)
  • TABLE 80. UK cancer gene therapy market size, by product, 2019 - 2025 (USD Million)
  • TABLE 81. UK cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 82. UK cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 83. France cancer gene therapy market size, by type, 2014 - 2018 (USD Million)
  • TABLE 84. France cancer gene therapy market size, by type, 2019 - 2025 (USD Million)
  • TABLE 85. France cancer gene therapy market size, by product, 2014 - 2018 (USD Million)
  • TABLE 86. France cancer gene therapy market size, by product, 2019 - 2025 (USD Million)
  • TABLE 87. France cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 88. France cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 89. Italy cancer gene therapy market size, by type, 2014 - 2018 (USD Million)
  • TABLE 90. Italy cancer gene therapy market size, by type, 2019 - 2025 (USD Million)
  • TABLE 91. Italy cancer gene therapy market size, by product, 2014 - 2018 (USD Million)
  • TABLE 92. Italy cancer gene therapy market size, by product, 2019 - 2025 (USD Million)
  • TABLE 93. Italy cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 94. Italy cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 95. Spain cancer gene therapy market size, by type, 2014 - 2018 (USD Million)
  • TABLE 96. Spain cancer gene therapy market size, by type, 2019 - 2025 (USD Million)
  • TABLE 97. Spain cancer gene therapy market size, by product, 2014 - 2018 (USD Million)
  • TABLE 98. Spain cancer gene therapy market size, by product, 2019 - 2025 (USD Million)
  • TABLE 99. Spain cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 100. Spain cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 101. Asia Pacific cancer gene therapy market size, by country, 2014 - 2025 (USD Million)
  • TABLE 102. Asia Pacific cancer gene therapy market size, by country, 2019 - 2025 (USD Million)
  • TABLE 103. Asia Pacific cancer gene therapy market size, by type, 2014 - 2018 (USD Million)
  • TABLE 104. Asia Pacific cancer gene therapy market size, by type, 2019 - 2025 (USD Million)
  • TABLE 105. Asia Pacific cancer gene therapy market size, by product, 2014 - 2018 (USD Million)
  • TABLE 106. Asia Pacific cancer gene therapy market size, by product, 2019 - 2025 (USD Million)
  • TABLE 107. Asia Pacific cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 108. Asia Pacific cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 109. China cancer gene therapy market size, by type, 2014 - 2018 (USD Million)
  • TABLE 110. China cancer gene therapy market size, by type, 2019 - 2025 (USD Million)
  • TABLE 111. China cancer gene therapy market size, by product, 2014 - 2018 (USD Million)
  • TABLE 112. China cancer gene therapy market size, by product, 2019 - 2025 (USD Million)
  • TABLE 113. China cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 114. China cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 115. Japan cancer gene therapy market size, by type, 2014 - 2018 (USD Million)
  • TABLE 116. Japan cancer gene therapy market size, by type, 2019 - 2025 (USD Million)
  • TABLE 117. Japan cancer gene therapy market size, by product, 2014 - 2018 (USD Million)
  • TABLE 118. Japan cancer gene therapy market size, by product, 2019 - 2025 (USD Million)
  • TABLE 119. Japan cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 120. Japan cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Cancer gene therapy market, 2014 - 2018 (USD Million)
  • FIG. 3 Growth potential analysis, by type
  • FIG. 4 Growth potential analysis, by product
  • FIG. 5 Growth potential analysis, by end-use
  • FIG. 6 Porter's analysis
  • FIG. 7 Strategy dashboard
  • FIG. 8 PESTEL analysis